[
    [
        {
            "time": "",
            "original_text": "浙商证券维持凯莱英买入评级，凯莱英更新报告：四论业绩确定性加速趋势和长期天花板打开",
            "features": {
                "keywords": [
                    "凯莱英",
                    "买入评级",
                    "业绩确定性",
                    "加速趋势",
                    "长期天花板"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "浙商证券维持凯莱英买入评级，凯莱英更新报告：四论业绩确定性加速趋势和长期天花板打开",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "行业观察|医药外包止跌回升背后：头部大企业绩纷纷高增CXO行业未来预期到底如何？",
            "features": {
                "keywords": [
                    "医药外包",
                    "止跌回升",
                    "头部企业",
                    "高增长",
                    "CXO行业",
                    "未来预期"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO",
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "行业观察|医药外包止跌回升背后：头部大企业绩纷纷高增CXO行业未来预期到底如何？",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "凯莱英(002821)：四论业绩确定性加速趋势和长期天花板打开",
            "features": {
                "keywords": [
                    "凯莱英",
                    "业绩确定性",
                    "加速趋势",
                    "长期天花板"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "凯莱英(002821)：四论业绩确定性加速趋势和长期天花板打开",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "CRO概念持续拉升，昭衍新药涨停，博腾股份、凯莱英、康龙化成跟涨。",
            "features": {
                "keywords": [
                    "CRO概念",
                    "拉升",
                    "昭衍新药",
                    "涨停",
                    "博腾股份",
                    "凯莱英",
                    "康龙化成",
                    "跟涨"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "CRO概念持续拉升，昭衍新药涨停，博腾股份、凯莱英、康龙化成跟涨。",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]